ARTICLE | Company News
Antares, BioSante deal
January 12, 2009 8:00 AM UTC
Antares received a $450,000 milestone payment from BioSante under a 2000 deal that gave BioSante exclusive rights to Elestrin estradiol (formerly Bio-E-Gel). The payment was triggered by BioSante's ...